CRL · 10-Q · 2026Q3 · Full report
Operating Cash Flow Trends
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-11-04 · Importance 29 · Surprise 22 · From source text
Net cash provided by operating activities was $474.9 million for the nine months ended September 26, 2026, down from $590.1 million in the same 2025 period. The $115.2 million decline primarily reflected higher first-quarter annual incentive bonus payments and higher professional services fees for enterprise-wide efficiency initiatives and acquisition, integration, and divestiture activities. Net income was $318.9 million, while adjustments reconciling net income to operating cash flow were $182.1 million and changes in assets and liabilities used $26.1 million.
Key facts
- Operating cash flows were $474.9 million in the nine months ended September 26, 2026, compared with $590.1 million in the same 2025 period. source
- The operating cash flow decline was primarily related to higher variable compensation payments, including first-quarter annual incentive bonuses, and higher professional-services fees for enterprise-wide efficiency initiatives and acquisition, integration and divestiture activities. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -1.6% | Operating cash flows were $474.9 million in the nine months ended September 26, 2026, compared with $590.1 million in the same 2025 period. |